CSL Limited
OTC: CSLLY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gordon Naylor DipCompSc
- Employees
- 32,698
- Headquarters
- Melbourne, Australia
- IPO year
- 2009
- Market cap
- $73.6B
- Website
- https://www.csl.com.au
Loading CSLLY…
Loading profile data…Frequently asked questions about CSLLY
What does CSL Limited (CSLLY) do?
CSL Limited is a global biopharmaceutical enterprise dedicated to the research, development, production, marketing, and distribution of a wide array of biopharmaceutical and related healthcare products. The company boasts a significant international presence, with operations spanning major markets such as Australia, the United States, Germany, t...
Where does CSLLY trade?
CSL Limited (CSLLY) trades on the Other OTC.
What sector is CSLLY in?
CSL Limited (CSLLY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CSL Limited?
Gordon Naylor DipCompSc is the chief executive officer of CSL Limited (CSLLY).
Where is CSL Limited headquartered?
CSL Limited is headquartered in Australia.
Does CSLLY pay a dividend?
Yes — CSL Limited (CSLLY) paid a trailing twelve-month dividend of USD 0.72 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CSLLY go public?
CSL Limited (CSLLY) completed its initial public offering in 2009.
Is CSLLY an ADR?
Yes — CSLLY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. CSL Limited reporting and dividends follow the underlying issuer.